HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,370.00
+25.00 (0.75%)
At close: Dec 5, 2025

HLB Therapeutics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
282,937934,494331,363365,136378,914776,712
Upgrade
Market Cap Growth
-61.59%182.02%-9.25%-3.64%-51.22%0.46%
Upgrade
Enterprise Value
301,673946,064315,400359,859380,861785,427
Upgrade
Last Close Price
3370.0011152.384176.195152.986290.0812980.24
Upgrade
Forward PE
-----108.87
Upgrade
PS Ratio
4.4717.016.308.618.6918.09
Upgrade
PB Ratio
1.675.141.932.852.917.74
Upgrade
P/TBV Ratio
5.286.372.213.283.319.64
Upgrade
P/FCF Ratio
58.671435.95109.54---
Upgrade
P/OCF Ratio
46.25725.6899.60---
Upgrade
EV/Sales Ratio
4.7717.226.008.498.7418.30
Upgrade
EV/EBITDA Ratio
-2022.13----
Upgrade
EV/FCF Ratio
62.551453.73104.26---
Upgrade
Debt / Equity Ratio
0.130.130.060.410.390.13
Upgrade
Debt / EBITDA Ratio
-49.91----
Upgrade
Debt / FCF Ratio
4.5935.883.31---
Upgrade
Asset Turnover
0.290.260.270.230.280.33
Upgrade
Inventory Turnover
8.068.407.707.6613.8211.14
Upgrade
Quick Ratio
0.921.461.581.241.911.82
Upgrade
Current Ratio
1.161.701.861.372.002.07
Upgrade
Return on Equity (ROE)
-4.97%-12.97%-1.98%-8.97%-15.42%-19.73%
Upgrade
Return on Assets (ROA)
-2.22%-2.27%-2.85%-2.49%-4.45%-5.39%
Upgrade
Return on Capital (ROIC)
-2.52%-2.46%-3.06%-2.60%-4.70%-5.91%
Upgrade
Return on Capital Employed (ROCE)
-4.20%-4.10%-5.10%-5.80%-8.30%-10.90%
Upgrade
Earnings Yield
-2.82%-2.44%-0.69%-3.11%-4.54%-2.18%
Upgrade
FCF Yield
1.70%0.07%0.91%-3.34%-3.19%-1.51%
Upgrade
Buyback Yield / Dilution
-2.37%-6.36%-14.46%-10.86%-7.26%-4.63%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.